by Reuters | Jun 29, 2023 | Health, Top News
By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical’s gene therapy for severe hemophilia A, the company said, giving patients with the inherited bleeding disorder an alternative to regular injections of...
by Reuters | Jun 27, 2023 | Business, Europe, Health, Top News, US
By Khushi Mandowara (Reuters) – U.S. health regulators on Tuesday declined to approve a higher-dose version of Regeneron Pharmaceuticals’ drug Eylea for treatment of a disease that is leading cause of blindness among the elderly, the company said as shares...
by Reuters | Jun 23, 2023 | Health, Politics, Top News, US
By Leah Douglas (Reuters) – The U.S. Department of Agriculture will spend $502 million to ensure its rapid response to any future bird flu cases as the country’s worst-ever outbreak of the virus levels off, the agency said Friday. Bird flu has killed 58.7...
by Reuters | Jun 22, 2023 | Health, Top News
By Leroy Leo and Aditya Samal (Reuters) – The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics’ first-of-its-kind gene therapy for Duchenne muscular dystrophy (DMD), an inherited progressive muscle-wasting disorder that almost...
by Reuters | Jun 12, 2023 | Business, Economy, Europe, Health, Top News, US
By Ludwig Burger and Patricia Weiss HAMBURG (Reuters) -BioNTech will go to court on Monday to defend itself against a lawsuit from a German woman who is seeking damages for alleged side effects of its COVID-19 vaccine, the first of potentially hundreds of cases in the...
by Reuters | Jun 9, 2023 | Business, Economy, Health, Politics, Top News, US
By Brendan Pierson (Reuters) – A mandate that U.S. health insurers cover preventive care like cancer screenings and HIV-preventing medication at no extra cost to patients could remain in place while the Biden administration appeals a court order striking it...
